Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Sterilization and Disinfection Control19.34M36.16%
Clinical Genomics12.55M23.46%
Calibration Solutions12.16M22.74%
Biopharmaceutical Development9.43M17.64%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States117.28M53.53%
Other76M34.69%
People's Republic of China25.8M11.78%
